60 Degrees Pharmaceuticals
SXTP · NASDAQ
$0.9222+$0.0229 (+2.55%)TodayMarket closed ·
Prev close $0.8993
Who owns SXTP
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 47.2% of SXTP’s shares.
- Knight Therapeutics, Inc.24.8%
- Kathmere Capital Management10.0%
- The Lind Partners, LLC7.2%
- Orca Capital GmbH1.6%
- Next 6 largest institutions3.8%
- All other shareholders52.8%
| Holder | Shares | % of shares |
|---|---|---|
| Knight Therapeutics, Inc. | 658.63K | 24.76% |
| Kathmere Capital Management | 265.10K | 9.97% |
| The Lind Partners, LLC | 191.57K | 7.20% |
| Orca Capital GmbH | 41.56K | 1.56% |
| Citadel Advisors LLC | 22.36K | 0.84% |
| XTX Markets LLC | 17.64K | 0.66% |
| Dow (Geoffrey S) | 16.78K | 0.63% |
| Kovack Advisors Inc | 15.00K | 0.56% |
| Geode Capital Management, L.L.C. | 14.55K | 0.55% |
| UBS Financial Services, Inc. | 13.59K | 0.51% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 14.38K | 0.54% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $10.13K (1 trade) of SXTP on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| DOW GEOFFREY S | Buy | 7.35K | $10.13K |
Short interest
Settled Sep 30, 2026
- Shares short
- 133.35K
- Days to cover
- 1.61
- % of shares outstanding
- 5.01%
- Average daily volume
- 82.82K
- Change since last report
- −38.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.